A tripeptide Diapin effectively lowers blood glucose levels in male type 2 diabetes mice by increasing blood levels of insulin and GLP-1.

The prevalence of type 2 diabetes (T2D) is rapidly increasing worldwide. Effective therapies, such as insulin and Glucagon-like peptide-1 (GLP-1), require injections, which are costly and result in less patient compliance. Here, we report the identification of a tripeptide with significant potential...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jifeng Zhang, Changyong Xue, Tianqing Zhu, Anuradha Vivekanandan, Subramaniam Pennathur, Zhongmin Alex Ma, Y Eugene Chen
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/27103078f08840d5b187d6ab48190712
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!